A Randomized, Prospective, Double Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of NutrichargeÂ® S F on Weight Maintenance in Obese Subjects - Nutricharge S F

Ms Trophic Wellness Pvt Ltd0 个研究点目标入组 100 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Male and female subjects aged between 18 and 65 Years.
•2.BMI >= 30 and <= 47
•3.Subjects able to communicate effectively.
•4.In the judgment of the Principal Investigator, able to comply with protocol requirements

•1.Contraindications or Hypersensitivity to study product or placebo.
•2.History or presence of any medical condition or disease according to the discretion of the Investigator.
•3.Clinically relevant conditions expected to preclude achievement of exercise recommendation.
•4.Current use of vitamin or mineral supplements, nutritional supplements and or medical foods within 30 days prior to the beginning of the study and for the duration of the study.
•5.Use of prescription medications and/or nonprescription medications for acute medical conditions, semi-acute medical conditions, and weight loss.
•6.Use of medications known to result in significant weight gain (e.g., oral steroids or second generation anti-psychotics)
•7.Hepatic, renal, gastrointestinal, respiratory, cardiovascular, endocrinologic, neurologic, immunologic, or hematologic disease.
•8.Diabetes mellitus, irritable bowel syndrome, Gastro-esophageal reflux disease, HIV, hepatitis B or C, malignancy, sleep apnea, insomnia (requiring use of sleeping medication more than once weekly), night eating syndrome, Anorexia nervosa, bulimia, of non-specific eating disorder, and serious psychiatric illness
•9.Female subjects who are currently pregnant and breast feeding
•10.Current diagnosis or history of alcoholism or drug dependence.
•11.Currently taking any medication on a regular basis.
•12.Use of any experimental medication within 1 month prior to screening or as concomitant medications.

发起方

Ms Trophic Wellness Pvt Ltd